63 related articles for article (PubMed ID: 9699675)
1. Altered expression of ubiquitous kinesin heavy chain results in resistance to etoposide and hypersensitivity to colchicine: mapping of the domain associated with drug response.
Axenovich SA; Kazarov AR; Boiko AD; Armin G; Roninson IB; Gudkov AV
Cancer Res; 1998 Aug; 58(15):3423-8. PubMed ID: 9699675
[TBL] [Abstract][Full Text] [Related]
2. Cloning mammalian genes by expression selection of genetic suppressor elements: association of kinesin with drug resistance and cell immortalization.
Gudkov AV; Kazarov AR; Thimmapaya R; Axenovich SA; Mazo IA; Roninson IB
Proc Natl Acad Sci U S A; 1994 Apr; 91(9):3744-8. PubMed ID: 8170981
[TBL] [Abstract][Full Text] [Related]
3. Identification of new drug sensitivity genes using genetic suppressor elements: protein arginine N-methyltransferase mediates cell sensitivity to DNA-damaging agents.
Gros L; Delaporte C; Frey S; Decesse J; de Saint-Vincent BR; Cavarec L; Dubart A; Gudkov AV; Jacquemin-Sablon A
Cancer Res; 2003 Jan; 63(1):164-71. PubMed ID: 12517794
[TBL] [Abstract][Full Text] [Related]
4. The C-terminal region of the stalk domain of ubiquitous human kinesin heavy chain contains the binding site for kinesin light chain.
Diefenbach RJ; Mackay JP; Armati PJ; Cunningham AL
Biochemistry; 1998 Nov; 37(47):16663-70. PubMed ID: 9843434
[TBL] [Abstract][Full Text] [Related]
5. Cloning by insertional mutagenesis of a cDNA encoding Caenorhabditis elegans kinesin heavy chain.
Patel N; Thierry-Mieg D; Mancillas JR
Proc Natl Acad Sci U S A; 1993 Oct; 90(19):9181-5. PubMed ID: 8105472
[TBL] [Abstract][Full Text] [Related]
6. Cloning and expression of a human kinesin heavy chain gene: interaction of the COOH-terminal domain with cytoplasmic microtubules in transfected CV-1 cells.
Navone F; Niclas J; Hom-Booher N; Sparks L; Bernstein HD; McCaffrey G; Vale RD
J Cell Biol; 1992 Jun; 117(6):1263-75. PubMed ID: 1607388
[TBL] [Abstract][Full Text] [Related]
7. Kinesin family in murine central nervous system.
Aizawa H; Sekine Y; Takemura R; Zhang Z; Nangaku M; Hirokawa N
J Cell Biol; 1992 Dec; 119(5):1287-96. PubMed ID: 1447303
[TBL] [Abstract][Full Text] [Related]
8. Transfection of a human topoisomerase II alpha gene into etoposide-resistant human breast tumor cells sensitizes the cells to etoposide.
Asano T; An T; Zwelling LA; Takano H; Fojo AT; Kleinerman ES
Oncol Res; 1996; 8(3):101-10. PubMed ID: 8823806
[TBL] [Abstract][Full Text] [Related]
9. Identification of a novel human kinesin-related gene (HK2) by the cDNA differential display technique.
Debernardi S; Fontanella E; De Gregorio L; Pierotti MA; Delia D
Genomics; 1997 May; 42(1):67-73. PubMed ID: 9177777
[TBL] [Abstract][Full Text] [Related]
10. Identification, partial characterization, and genetic mapping of kinesin-like protein genes in mouse.
Yang Z; Hanlon DW; Marszalek JR; Goldstein LS
Genomics; 1997 Oct; 45(1):123-31. PubMed ID: 9339368
[TBL] [Abstract][Full Text] [Related]
11. Cloning and localization of a conventional kinesin motor expressed exclusively in neurons.
Niclas J; Navone F; Hom-Booher N; Vale RD
Neuron; 1994 May; 12(5):1059-72. PubMed ID: 7514426
[TBL] [Abstract][Full Text] [Related]
12. Identification and cloning of EI24, a gene induced by p53 in etoposide-treated cells.
Lehar SM; Nacht M; Jacks T; Vater CA; Chittenden T; Guild BC
Oncogene; 1996 Mar; 12(6):1181-7. PubMed ID: 8649819
[TBL] [Abstract][Full Text] [Related]
13. Chromosomal localization reveals three kinesin heavy chain genes in mouse.
Xia Ch; Rahman A; Yang Z; Goldstein LS
Genomics; 1998 Sep; 52(2):209-13. PubMed ID: 9782088
[TBL] [Abstract][Full Text] [Related]
14. Alteration of substrate specificity by mutations at the His61 position in predicted transmembrane domain 1 of human MDR1/P-glycoprotein.
Taguchi Y; Kino K; Morishima M; Komano T; Kane SE; Ueda K
Biochemistry; 1997 Jul; 36(29):8883-9. PubMed ID: 9220975
[TBL] [Abstract][Full Text] [Related]
15. Cytotoxicity of etoposide in cancer cell lines in vitro after BCL-2 and C-RAF gene silencing with antisense oligonucleotides.
Sypniewski D; Bednarek I; Gałka S; Loch T; Błaszczyk D; Sołtysik D
Acta Pol Pharm; 2013; 70(1):87-97. PubMed ID: 23610963
[TBL] [Abstract][Full Text] [Related]
16. Drug resistance patterns of human neuroblastoma cell lines derived from patients at different phases of therapy.
Keshelava N; Seeger RC; Groshen S; Reynolds CP
Cancer Res; 1998 Dec; 58(23):5396-405. PubMed ID: 9850071
[TBL] [Abstract][Full Text] [Related]
17. KIF3C, a novel member of the kinesin superfamily: sequence, expression, and mapping to human chromosome 2 at 2p23.
Sardella M; Navone F; Rocchi M; Rubartelli A; Viggiano L; Vignali G; Consalez GG; Sitia R; Cabibbo A
Genomics; 1998 Feb; 47(3):405-8. PubMed ID: 9480755
[TBL] [Abstract][Full Text] [Related]
18. Effect of disruption of the cytoskeleton on smooth muscle contraction.
Battistella-Patterson AS; Wang S; Wright GL
Can J Physiol Pharmacol; 1997 Dec; 75(12):1287-99. PubMed ID: 9534938
[TBL] [Abstract][Full Text] [Related]
19. Molecular cloning and functional analysis of mouse C-terminal kinesin motor KifC3.
Yang Z; Xia Ch; Roberts EA; Bush K; Nigam SK; Goldstein LS
Mol Cell Biol; 2001 Feb; 21(3):765-70. PubMed ID: 11154264
[TBL] [Abstract][Full Text] [Related]
20. Adenovirus-mediated human topoisomerase IIalpha gene transfer increases the sensitivity of etoposide-resistant human and mouse breast cancer cells.
Asano T; Kleinerman ES; Zwelling LA; Zhou Z; Fukunaga Y
Acta Oncol; 2005; 44(3):240-7. PubMed ID: 16076696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
